Correction to “Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights”
Correction 1: Table 1.The analyses were conducted using the correct data, and all results, interpretations, and conclusions in the paper remain fully accurate.The issue is limited to the presentation of values in the table.Correction 2: p 4733, second paragraph, 1 st sentence.Thigmotaxis was evaluated to assess potential anxiety-like effects induced by the compounds.When comparing the tested doses of SDA and SDMA (2.5, 10, and 25 mg/kg) with saline (Figure 5B and 5E, respectively), a significant increase in thigmotaxis, reflected by reduced time spent in the center of the arena, was observed only for SDA at 10 mg/kg.
Authors
- Matthias Grill
- Selina Hemmer (ORCID: https://orcid.org/0009-0009-5534-0612)
- Raúl López‐Arnau (ORCID: https://orcid.org/0000-0001-8904-7398)
- Kathrin Jäntsch
- Tamara Hell
- Thomas Stockner (ORCID: https://orcid.org/0000-0002-7071-8283)
- Marion Holy
- Nina Kastner (ORCID: https://orcid.org/0000-0002-1576-9029)
- Harald H. Sitte (ORCID: https://orcid.org/0000-0002-1339-7444)
- Fatemeh Kooti
- Naomi Shacham
- Giulia Cicalese
- Markus R. Meyer
- Núria Nadal-Gratacós
- Adam L. Halberstadt
- Bruna Cuccurazzu
- John L. McKee
- Letícia Aparecida Lopes Bezerra da Silva
- Ricarda Baron
Publication Details
- Journal
- ACS Chemical Neuroscience
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1021/acschemneuro.6c00136
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00